What does SPRINGFIELD NUTRACEUTICALS BELGIUM do?

SPRINGFIELD NUTRACEUTICALS BELGIUM is a commercial agency in Heist-op-den-Berg. Private Limited, started on 1 September 2006, 1 establishment.

What is the address of SPRINGFIELD NUTRACEUTICALS BELGIUM?

The registered office of SPRINGFIELD NUTRACEUTICALS BELGIUM is located at Lodewijk Liekenswijk 10B, 2220 Heist-op-den-Berg.

Is SPRINGFIELD NUTRACEUTICALS BELGIUM still active?

Yes. According to the CBE (2 November 2026) SPRINGFIELD NUTRACEUTICALS BELGIUM is active, legal situation “Normale toestand”, started on 1 September 2006.

Is SPRINGFIELD NUTRACEUTICALS BELGIUM registered on Peppol?

No, SPRINGFIELD NUTRACEUTICALS BELGIUM is currently not registered on the Peppol network.

What is the enterprise number of SPRINGFIELD NUTRACEUTICALS BELGIUM?

The enterprise number of SPRINGFIELD NUTRACEUTICALS BELGIUM is BE0883345544.

When was SPRINGFIELD NUTRACEUTICALS BELGIUM founded?

SPRINGFIELD NUTRACEUTICALS BELGIUM was founded on 1 September 2006.

Who are the directors of SPRINGFIELD NUTRACEUTICALS BELGIUM?

According to the 2025 annual accounts, the directors of SPRINGFIELD NUTRACEUTICALS BELGIUM are: SPRINGFIELD NUTRACEUTICALS BV BO, Jelle D'HELFT.

Is SPRINGFIELD NUTRACEUTICALS BELGIUM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 September 2006; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

How much profit did SPRINGFIELD NUTRACEUTICALS BELGIUM make in 2025?

SPRINGFIELD NUTRACEUTICALS BELGIUM recorded a loss after taxes of € 29,475 in financial year 2025.

What is the revenue of SPRINGFIELD NUTRACEUTICALS BELGIUM?

As a small company, SPRINGFIELD NUTRACEUTICALS BELGIUM is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -27,770.

SPRINGFIELD NUTRACEUTICALS BELGIUM (Private Limited)

Dossier SPRINGFIELD NUTRACEUTICALS BELGIUM, printed on 3 November 2026 from databakkes.be/en/0883345544/springfield-nutraceuticals-belgium. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

SPRINGFIELD NUTRACEUTICALS BELGIUM from Heist-op-den-Berg, company number BE0883345544, closed financial year 2025 with a result of € -29,475 after tax. For that financial year SPRINGFIELD NUTRACEUTICALS BELGIUM recorded a gross margin of € -27,770 and equity of € 19,828. Compared with financial year 2024, the result moved from € 12,041 to € -29,475. The company made a loss. The buffer shrank hard: equity is 60 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Shrank hard

€ 19,828

▼ 60% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -29,475

▼ still € 12,041 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 85,263

▲ € 69,439 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 1,228.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 791

▼ 48% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,380

▼ 88% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 63,981

▲ 286% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 14,686 Gross margin 2022: € 14,686 First fiscal year in the series	€ 34,463 Gross margin 2023: € 34,463 ▲ 135% vs 2022 (€ 14,686) Favourable step	€ 24,070 Gross margin 2024: € 24,070 ▼ 30% vs 2023 (€ 34,463) Unfavourable step	€ -27,770 Gross margin 2025: € -27,770 ▼ € 51,840 vs 2024 (€ 24,070) Unfavourable step	▼ € 51,840
Profit after taxes	€ 6,216 Profit after taxes 2022: € 6,216 First fiscal year in the series	€ 17,721 Profit after taxes 2023: € 17,721 ▲ 185% vs 2022 (€ 6,216) Favourable step	€ 12,041 Profit after taxes 2024: € 12,041 ▼ 32% vs 2023 (€ 17,721) Unfavourable step	€ -29,475 Profit after taxes 2025: € -29,475 ▼ € 41,516 vs 2024 (€ 12,041) Unfavourable step	▼ € 41,516
Equity	€ 31,541 Equity 2022: € 31,541 First fiscal year in the series	€ 37,263 Equity 2023: € 37,263 ▲ 18% vs 2022 (€ 31,541) Favourable step	€ 49,304 Equity 2024: € 49,304 ▲ 32% vs 2023 (€ 37,263) Favourable step	€ 19,828 Equity 2025: € 19,828 ▼ 60% vs 2024 (€ 49,304) Unfavourable step	▼ 60%
Total debts	€ 42,218 Total debts 2022: € 42,218 First fiscal year in the series	€ 25,019 Total debts 2023: € 25,019 ▼ 41% vs 2022 (€ 42,218) Favourable step	€ 30,227 Total debts 2024: € 30,227 ▲ 21% vs 2023 (€ 25,019) Unfavourable step	€ 66,711 Total debts 2025: € 66,711 ▲ 121% vs 2024 (€ 30,227) Unfavourable step	▲ 121%
Cash	€ 3,006 Cash 2022: € 3,006 First fiscal year in the series	€ 18,764 Cash 2023: € 18,764 ▲ € 15,758 vs 2022 (€ 3,006) Favourable step	€ 15,824 Cash 2024: € 15,824 ▼ 16% vs 2023 (€ 18,764) Unfavourable step	€ 85,263 Cash 2025: € 85,263 ▲ € 69,439 vs 2024 (€ 15,824) Favourable step	▲ € 69,439
Retained profit	€ 12,941 Retained profit 2022: € 12,941 First fiscal year in the series	€ 18,663 Retained profit 2023: € 18,663 ▲ 44% vs 2022 (€ 12,941) Favourable step	€ 30,704 Retained profit 2024: € 30,704 ▲ 65% vs 2023 (€ 18,663) Favourable step	€ 1,228 Retained profit 2025: € 1,228 ▼ 96% vs 2024 (€ 30,704) Unfavourable step	▼ 96%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 12,000 Dividend 2023: € 12,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 12,000) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 73,759 Balance sheet total 2022: € 73,759 First fiscal year in the series	€ 62,282 Balance sheet total 2023: € 62,282 ▼ 16% vs 2022 (€ 73,759) Unchanged	€ 79,531 Balance sheet total 2024: € 79,531 ▲ 28% vs 2023 (€ 62,282) Unchanged	€ 86,540 Balance sheet total 2025: € 86,540 ▲ 9% vs 2024 (€ 79,531) Unchanged	▲ 9%

Key figures of SPRINGFIELD NUTRACEUTICALS BELGIUM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to SPRINGFIELD NUTRACEUTICALS BELGIUM?

What happened at SPRINGFIELD NUTRACEUTICALS BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: loss of € 29,475 (▼ € 41,516 vs 2024). filed late Source: NBB ↗
Feb 2, 2007 New establishment in Heist-op-den-Berg. KBO
Sep 14, 2006 Incorporation, published in the Gazette. Source: Staatsblad ↗
2006 Jelle D'HELFT became a director. NBB

In short

From € 6,216 profit in 2022 to € 29,475 loss in 2025.

Paid € 17,195 in corporate taxes since 2022.

Best year ever: 2023, with € 17,721 profit.

Paid out € 12,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

SPRINGFIELD NUTRACEUTICALS BV BO Jelle D'HELFT

SPRINGFIELD NUTRACEUTICALS BELGIUM

Behind SPRINGFIELD NUTRACEUTICALS BELGIUM are SPRINGFIELD NUTRACEUTICALS BV BO and Jelle D'HELFT.

Directors

According to the 2025 annual accounts

SPRINGFIELD NUTRACEUTICALS BV BO

Director · represented by Linda NATEROP

Jelle D'HELFT

Director

since 2006

Establishments

Establishment units

Physical locations of this company

Registered office

Lodewijk Liekenswijk 10B

2220 Heist-op-den-Berg

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

14 September 2006 Source: Deed ↗

SPRINGFIELD NUTRACEUTICALS BV(oprichter) 100%

Details

Company number

0883.345.544

VAT number

BE 0883.345.544

Registered office

Lodewijk Liekenswijk 10B, 2220 Heist-op-den-Berg

Names & denominations

SPRINGFIELD NUTRACEUTICALS BELGIUM

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 September 2006

Peppol

Not registered

Activities · NACE

Handelsbemiddeling in de groothandel in voedings- en genotmiddelen

Handelsbemiddeling in voedings- en genotmiddelen

Overige detailhandel in voedingsmiddelen, neg

Overige detailhandel in voedings- en genotmiddelen in gespecialiseerde winkels, n.e.g.

Overige detailhandel in voedingsmiddelen in gespecialiseerde winkels, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

SPRINGFIELD NUTRACEUTICALS BELGIUM

Warning lights

Financials

What happened to SPRINGFIELD NUTRACEUTICALS BELGIUM?

Management

Directors

Establishments

Establishment units

Shareholders according to the Official Gazette deeds

Details

Frequently asked questions